VAERS reports by lot

Janssen (J&J) COVID-19 lot 1821288: VAERS reports

178 VAERS reports list lot 1821288 as a Janssen (J&J) COVID-19 vaccine, received between 2021-05-29 and 2024-12-04. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
178
Reports
8%
Marked serious
2
With a death outcome
16
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological15428%
General / Systemic (non-local)8816%
Cardiac / Cardiovascular5510%
Gastrointestinal5310%
Dermatological (non-injection-site)458%
Musculoskeletal397%
Injection-site / Local reaction387%
Respiratory316%
Allergic / Anaphylactic193%
Thrombotic / Hematological122%
Psychiatric / Neuropsychiatric92%
Autoimmune / Immune-mediated71%
Reproductive / Menstrual71%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois16
Virginia14
Missouri11
Michigan10
North Carolina10
Ohio9
Florida9
Texas9
Wisconsin8
New York8
Oklahoma8
Iowa7

Reports by month received

2021-057
2021-0697
2021-0732
2021-089
2021-097
2021-106
2021-111
2021-122
2022-015
2022-022
2022-033
2022-052
2022-062
2022-091
2022-121
2024-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.